Align Technology Inc., a leading global medical device company, announced that its Invisalign® Palatal Expander System has been approved by the National Medical Products Administration (NMPA) in China. This system is designed for skeletal and dental malocclusion in primary, mixed, and permanent dentition and will be commercially available in the second half of 2025. The approval represents a significant milestone in providing a comprehensive early intervention treatment solution, enhancing clinical outcomes and efficiency in orthodontics. This marks the first time Align's direct 3D printed orthodontic appliance will be available in China, expanding its reach in the Asia Pacific region.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.